Your session is about to expire
← Back to Search
PRISM for Post-Traumatic Stress Disorder
N/A
Waitlist Available
Research Sponsored by GrayMatters Health Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 22 to 65
Any gender
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline visit (week 1), post-intervention visit (week 9) and 3 month follow-up visit
Awards & highlights
Study Summary
This study is evaluating whether a process called neuro-modulation may help reduce symptoms of PTSD.
Eligible Conditions
- Post-Traumatic Stress Disorder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline visit (week 1), post-intervention visit (week 9) and 3 month follow-up visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline visit (week 1), post-intervention visit (week 9) and 3 month follow-up visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinician Administered PTSD Scale (CAPS - 5)
Secondary outcome measures
Clinical Global Impression (CGI)
ERQ score
PCL-5 response rate
+1 moreOther outcome measures
Abbreviated PCL (APCL)
Patient satisfaction survey
Remission rate
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Subjects diagnosed with PTSD will be recruited from the community and from local clinical programs. All subjects will undergo Prism neurofeedback training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PRISM
2016
N/A
~170
Find a Location
Who is running the clinical trial?
GrayMatters Health Ltd.Lead Sponsor
1 Previous Clinical Trials
80 Total Patients Enrolled
Adar ShaniStudy DirectorGrayMatters Health
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger